SCLX Q1 2022 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q1 2022 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$7M+23.5% YoY

Gross Profit

$6M83.2% margin

Operating Income

-$9M-129.3% margin

Net Income

-$9M-134.2% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

-17.6%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$110M

Total Liabilities

$342M

Stockholders' Equity

-$232M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$6M	+23.5%
Gross Profit	$6M	$5M	+21.5%
Operating Income	-$9M	-$11M	+22.3%
Net Income	-$9M	-$19M	+52.1%